PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Silk Road Medical, Inc (SILK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US82710M1009

CUSIP

82710M100

Sector

Healthcare

IPO Date

Apr 4, 2019

Highlights

Market Cap

$1.12B

EPS (TTM)

-$1.45

Total Revenue (TTM)

$99.73M

Gross Profit (TTM)

$75.01M

EBITDA (TTM)

-$30.25M

Year Range

$15.23 - $27.51

Target Price

$20.75

Short %

7.87%

Short Ratio

2.48

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
SILK vs. SLV SILK vs. NSPR
Popular comparisons:
SILK vs. SLV SILK vs. NSPR

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Silk Road Medical, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-4.00%-3.00%-2.00%-1.00%0.00%1.00%2.00%Fri 23Aug 25Tue 27Thu 29Sat 31Mon 02Wed 04Fri 06Sep 08Tue 10Thu 12Sat 14Mon 16Wed 18Fri 20Sep 22Tue 24Thu 26
1.21%
2.21%
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Returns By Period


SILK

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of SILK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202423.31%18.90%1.83%6.11%11.83%24.38%-0.11%0.37%124.04%
20232.86%-2.52%-26.16%12.50%-31.42%7.62%-29.70%-15.41%-22.41%-49.90%24.23%31.51%-76.78%
2022-23.00%13.17%11.20%-15.11%-5.22%9.54%25.06%-12.48%12.98%-2.04%20.80%-0.75%24.03%
2021-13.42%0.44%-7.52%20.71%-20.54%-1.48%4.85%18.13%-7.17%6.69%-30.88%5.00%-32.34%
202015.26%-14.37%-21.00%33.04%-8.62%9.46%10.91%31.25%10.22%-9.83%-5.45%9.91%55.97%
201915.09%2.45%13.60%-10.67%-0.46%-24.51%1.81%8.76%12.10%11.61%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of SILK is 69, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SILK is 6969
Overall Rank
The Sharpe Ratio Rank of SILK is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of SILK is 6363
Sortino Ratio Rank
The Omega Ratio Rank of SILK is 8080
Omega Ratio Rank
The Calmar Ratio Rank of SILK is 6969
Calmar Ratio Rank
The Martin Ratio Rank of SILK is 6666
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Silk Road Medical, Inc (SILK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
No data
SILK
^GSPC

There is not enough data available to calculate the Sharpe ratio for Silk Road Medical, Inc. We calculate this metric based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio0.501.001.502.002.50Fri 23Aug 25Tue 27Thu 29Sat 31Mon 02Wed 04Fri 06Sep 08Tue 10Thu 12Sat 14Mon 16Wed 18Fri 20Sep 22Tue 24Thu 26
0.99
2.75
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Silk Road Medical, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%Fri 23Aug 25Tue 27Thu 29Sat 31Mon 02Wed 04Fri 06Sep 08Tue 10Thu 12Sat 14Mon 16Wed 18Fri 20Sep 22Tue 24Thu 26
-60.69%
0
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Silk Road Medical, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Silk Road Medical, Inc was 91.01%, occurring on Oct 25, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-91.01%Nov 9, 2020745Oct 25, 2023
-52.85%Jun 20, 2019188Mar 18, 202097Aug 5, 2020285
-13.65%Sep 21, 202026Oct 26, 20208Nov 5, 202034
-12.49%May 23, 20197Jun 3, 20195Jun 10, 201912
-12.26%Apr 11, 20195Apr 17, 20195Apr 25, 201910

Volatility

Volatility Chart

The current Silk Road Medical, Inc volatility is 1.03%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


1.00%2.00%3.00%4.00%5.00%6.00%Fri 23Aug 25Tue 27Thu 29Sat 31Mon 02Wed 04Fri 06Sep 08Tue 10Thu 12Sat 14Mon 16Wed 18Fri 20Sep 22Tue 24Thu 26
1.03%
4.06%
SILK (Silk Road Medical, Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Silk Road Medical, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Silk Road Medical, Inc.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab